Hepatic secretion of lipid and apoB with MTP knockdown. by Stephanie M. Marshall (223125)

(a) Schematic of the sample preparation, (b) developed GFRPs samples modified, (c) samples for impact strength tests, (d) samples for compressive strength tests. by Shaban Gul (14309526)

Subjects:

Differences in abundance in liver of <i>Fmo5</i>^<i>-/-</i> and WT mice of products of microbial and host-conjugation reactions. by Ian R. Phillips (5074121)

Advanced glycation end-products (AGEs) increased the expressions of RAGE, p38 MAPK, and Bax and decreased the Bcl-2 expression. by Kuo-Cheng Lan (727846)

Liver expression of LDLR and ABCA1 protein in mice with hepatic MTP knockdown. by Stephanie M. Marshall (223125)

Hepatic and intestinal MTP expression following MTP ASO treatment. by Stephanie M. Marshall (223125)

Effect of squalene on antioxidative parameters from the three experimental models. by Clara Gabás-Rivera (613994)

Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. by Hong Tian (169626)

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt^WT]/+</i> (filled black circles) and <i>+/-;P[syt^P-L]/+</i> (filled red circles) larvae at Ca²⁺ levels ranging from 0.05 mM—5.0 mM. …”

Th2 cytokines and IgE were decreased in G-1-treated C57BL/6 mice compared to non-treated mice. by Masamichi Itoga (706167)

Effects of FE and RUD wrist postures on the mean shape signature phase shift within each quartile. by Drew A. Anderson (14197446)

Light adaptation of <i>TrUx;GapOx</i> rods. by Ala Morshedian (4165957)

RMSD graphs for the backbone of WT PARG1, I845V and T622M mutants. by Zen Kouchi (14898435)

NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

Evaluation of the PCSK9 vaccine (V2 vaccine) in male <i>ApoE-deficient mice</i> (N = 5–7). by Ryo Kawakami (4849549)

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Pooled estimate of sensitivity across mean Ct-values holding symptom status and IFU-status constant at their respective means. by Lukas E. Brümmer (11269299)

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

Y86 is critical for SERINC3/5 antagonism by SIVcol Nef. by Dorota Kmiec (5646374)

GluA1KO mice mimic the EAC3I mice decrease in sEPSC frequency. by Jason R. Klug (132807)